Skip to main content
SpringerLink
Log in

Retroperitoneale Fibrose (Morbus Ormond)

  • Chapter
  • First Online:
Die Urologie

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Bei der retroperitonealen Fibrose (RPF, Morbus Ormond) handelt es sich um eine seltene, chronische, entzündlich-fibrosierende Erkrankung des hinteren Bauchraumes. Sie ist gekennzeichnet durch die gutartige Vermehrung von retroperitonealem Weichteilgewebe. In ihrer typischen Lokalisation breitet sich die Fibrose symmetrisch um die Aorta aus, beginnt unterhalb der Nierenstielgefäße und reicht bis unterhalb der Aortenbifurkation. Bei ihrer Ausbreitung erreicht die Fibrose meist als erstes Organ die Ureteren, sodass eine obstruktive Uropathie mit konsekutiver Hydronephrose die häufigste Komplikation dieser Erkrankung ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Adler S, Lodermeyer S, Gaa J, Heemann U (2008) Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 47(10):1535–1538

    Article  CAS  Google Scholar 

  • Alberici F, Palmisano A et al (2013) Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis 72(9):1584–1586

    Article  CAS  PubMed  Google Scholar 

  • Armatys SA, Mellon MJ et al (2009) Use of ileum as ureteral replacement in urological reconstruction. J Urol 181(1):177–181

    Article  PubMed  Google Scholar 

  • Binder M, Christoph S et al (2012) Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 30(5):772–775

    PubMed  Google Scholar 

  • Brandt AS, Kamper L et al (2011) Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 185(2):526–531

    Article  CAS  PubMed  Google Scholar 

  • Brandt AS, Kamper L et al (2013) An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI. J Clin Med Res 5(1):49–56

    CAS  PubMed  PubMed Central  Google Scholar 

  • Brandt AS, Kamper L, Kukuk S, Haage P, Roth S (2014) Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Urol Int. 2014;93(3):320–325

    Google Scholar 

  • Brandt AS, Kukuk S, Dreger NM, Müller E, Roth S (2015) Therapie der retroperitonealen Fibrose: Funktionelle Behandlungsergebnisse, Urologe A. 2015 Jan;54(1):62–69

    Google Scholar 

  • Burkhardt Soares S, Fehr A et al (2007) Retroperitoneal fibrosis. Aktuelle Urol 38(3):221–231

    Article  CAS  PubMed  Google Scholar 

  • Burn PR, Singh S et al (2002) Role of gadolinium-enhanced magnetic resonance imaging in retroperitoneal fibrosis. Can Assoc Radiol J 53(3):168–170

    PubMed  Google Scholar 

  • Caiafa RO, Vinuesa AS et al (2013) Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics: Rev Publ Radiol Soc N Am Inc 33(2):535–552

    Article  Google Scholar 

  • Catanoso MG, Spaggiari L et al (2012) Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 30(5):776–778

    PubMed  Google Scholar 

  • Duchene DA, Winfield HN et al (2007) Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology 69(6):1017–1021

    Article  PubMed  Google Scholar 

  • Fry AC, Singh S et al (2008) Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 108(3):c213–c220

    Article  CAS  PubMed  Google Scholar 

  • Heidenreich A, Derakhshani P et al (2000) Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urologe A 39(2):141–148

    Article  CAS  PubMed  Google Scholar 

  • Ilie CP, Pemberton RJ et al (2006) Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment. BJU Int 98(1):137–140

    Article  PubMed  Google Scholar 

  • Kamper L, Brandt AS et al (2011) MR evaluation of retroperitoneal fibrosis. RoFo: Fortschr Gebiete Rontgenstrahlen Nuklearmedizin 183(8):721–726

    Article  CAS  Google Scholar 

  • Kamper L, Brandt AS, Ekamp H, Hofer M, Roth S, Haage P, Piroth W (2014) The potential role of modern US in the follow-up of patients with retroperitoneal fibrosis. Diagn Interv Radiol. 2014 Jan-Feb;20(1):3–8

    Google Scholar 

  • Kardar AH, Kattan S et al (2002) Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 168(2):550–555

    Article  CAS  PubMed  Google Scholar 

  • Khosroshahi A, Carruthers MN et al (2013) Rethinking Ormond's disease: „idiopathic“ retroperitoneal fibrosis in the era of IgG4-related disease. Medicine 92(2):82–91

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kukuk S, Kretschmer A, Bruck H, Roth S, Brandt AS. (2014) Retroperitoneale Fibrose: Entwicklung eines Biomarkerprofils zur Diagnostik und Verlaufskontrolle, Urologe A. 2015 Jan;54(1):52–61

    Google Scholar 

  • Magrey MN, Husni ME et al (2009) Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 61(5):674–679

    Article  CAS  PubMed  Google Scholar 

  • Marcolongo R, Tavolini IM et al (2004) Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 116(3):194–197

    Article  PubMed  Google Scholar 

  • Martorana D, Vaglio A et al (2006) Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 55(1):126–130

    Article  CAS  PubMed  Google Scholar 

  • Marzano A, Trapani A et al (2001) Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis 60(4):427–428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moroni G, Castellani M et al (2012) The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging 39(10):1635–1642

    Article  PubMed  Google Scholar 

  • Mufarrij PW, Stifelman MD (2006) Robotic ureterolysis, retroperitoneal biopsy, and omental wrap for the treatment of ureteral obstruction due to idiopathic retroperitoneal fibrosis. Rev Urol 8(4):226–230

    PubMed  PubMed Central  Google Scholar 

  • Pelkmans LG, Aarnoudse AJ et al (2012) Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant: Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 27(7):2819–2825

    Article  CAS  Google Scholar 

  • Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN (2009) Nephrogenic systemic fibrosis and its impact on abdominal imaging. Radiographics 29:1565–1574

    Article  PubMed  Google Scholar 

  • Scheel PJ Jr, Feeley N (2009) Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation. Medicine (Baltimore) 88(4):202–207

    Article  Google Scholar 

  • Scheel PJ Jr, Piccini J et al (2007) Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol 178(1):140–143, discussion 143–144

    Article  CAS  PubMed  Google Scholar 

  • Scheel PJ Jr, Sozio SM et al (2012) Medical management of retroperitoneal fibrosis. Trans Am Clin Climatol Assoc 123:283–290, discussion 290–281

    PubMed  PubMed Central  Google Scholar 

  • Stifelman MD, Shah O et al (2008) Minimally invasive management of retroperitoneal fibrosis. Urology 71(2):201–204

    Article  PubMed  Google Scholar 

  • Swartz RD (2009) Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kidney Dis 54:546–553

    Article  PubMed  Google Scholar 

  • Swartz RD, Lake AM et al (2008) Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil. Clin Nephrol 69(4):260–268

    Article  CAS  PubMed  Google Scholar 

  • Treglia G, Mattoli MV et al (2013) Emerging role of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review. Rheumatol Int 33(3):549–555

    Article  PubMed  Google Scholar 

  • Uibu T, Oksa P et al (2004) Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 363(9419):1422–1426

    Article  CAS  PubMed  Google Scholar 

  • Vaglio A (2009) Retroperitoneal fibrosis: new insights into clinical presentation and diagnosis. Medicine (Baltimore) 88(4):208–210

    Article  Google Scholar 

  • Vaglio A, Buzio C (2005) Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 17(1):34–40

    Article  PubMed  Google Scholar 

  • Vaglio A, Greco P et al (2006a) Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5(7):458–464

    Article  PubMed  Google Scholar 

  • Vaglio A, Salvarani C et al (2006b) Retroperitoneal fibrosis. Lancet 367(9506):241–251

    Article  PubMed  Google Scholar 

  • Vaglio A, Palmisano A et al (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378(9788):338–346

    Article  CAS  PubMed  Google Scholar 

  • van Bommel EF, Hendriksz TR et al (2006) Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 144(2):101–106

    Article  PubMed  Google Scholar 

  • van Bommel EF, Siemes C et al (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49(5):615–625

    Article  PubMed  Google Scholar 

  • van Bommel EF, Pelkmans LG et al (2013) Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Int Med 24(5):444–450

    Article  Google Scholar 

  • Vega J, Goecke H et al (2009) Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series. Am J Kidney Dis 53(4):628–637

    Article  CAS  PubMed  Google Scholar 

  • Warnatz K, Keskin AG et al (2005) Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 64(6):828–833

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zen Y, Onodera M et al (2009) Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 33(12):1833–1839

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie und Kinderurologie, Lehrstuhl für Urologie der Universität Witten/Herdecke, Helios Klinikum Wuppertal, Heusnerstr. 40, 42283, Wuppertal, Deutschland

    Alexander Sascha Brandt & Stephan Roth

  2. Institut für Pathologie und Molekularpathologie, Lehrstuhl für Pathologie der Universität Witten/Herdecke, Helios Klinikum Wuppertal, Heusnerstr. 40, 42283, Wuppertal, Deutschland

    Daniel Goedde & Stephan Störkel

  3. Zentrum für Radiologie, Lehrstuhl für klinische Radiologie der Universität Witten/Herdecke, Helios Klinikum Wuppertal, Heusnerstr. 40, 42283, Wuppertal, Deutschland

    Lars Kamper & Patrick Haage

Authors
  1. Alexander Sascha Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Goedde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lars Kamper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick Haage
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephan Störkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephan Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Sascha Brandt .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Mannheim, Klinik für Urologie, Mannheim, Baden-Württemberg, Germany

    Maurice Stephan Michel

  2. Klinik für Urologie, Universitätsklinik Mannheim, Mainz, Germany

    Joachim W. Thüroff

  3. Abt. für Urologie, Universitätsklinikum Salzburg, Salzburg, Austria

    Günther Janetschek

  4. Klinik und Poliklinik für Urologie, Univer Tech Univ Dresden, Dresden, Germany

    Manfred Wirth

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Brandt, A.S., Goedde, D., Kamper, L., Haage, P., Störkel, S., Roth, S. (2016). Retroperitoneale Fibrose (Morbus Ormond). In: Michel, M., Thüroff, J., Janetschek, G., Wirth, M. (eds) Die Urologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39940-4_112

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39940-4_112

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39939-8

  • Online ISBN: 978-3-642-39940-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation